Testing a tool during surgery for early endometrial cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at how well a surgical tool is used during standard surgery for early endometrial cancer, and whether it relates to test results from fluid taken in the abdomen. It may help surgeons improve how samples are collected and interpreted during routine care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and can give informed consent
- You have a biopsy-confirmed diagnosis of endometrial cancer
- Your plan is standard surgery for early stage endometrial cancer
- There is no known spread of cancer inside the abdomen
- Your final surgical/pathology results are expected to confirm endometrial cancer
- You are a good candidate for surgery and choose not to delay/avoid surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at better ways to predict how aggressive your endometrial cancer is before surgery, so doctors can decide if they need to check your lymph nodes. It may help tailor your treatment to avoid unnecessary procedures.
This trial is testing a newer, single-port robotic system (da Vinci SP) for staging surgery in endometrial cancer. It aims to see if this system is safe and effective for removing the uterus, ovaries, and possibly lymph nodes, with less scarring.
This is a research study that looks at outcomes in women with endometrial (uterine) cancer who receive the usual standard surgery. Researchers will group patients based on the final surgical and pathology results and what additional (if any) treatment is recommended afterward.
This study looks at combining genetic testing with surgical exams to better understand endometrial cancer. It may help doctors see which treatments could work best for you.
This study tests two less invasive methods—sampling cells from the lining of the uterus (endometrial cytology) and checking DNA changes in the cervix—to see if they can help detect endometrial cancer or atypical hyperplasia, and to monitor response in people who are preserving their fertility. It aims to find a gentler alternative to traditional biopsy.
This study tests a simple, non-invasive method to detect endometrial cancer in women after menopause who have abnormal bleeding. It aims to find cancer early in those at higher risk, such as women with certain genetic conditions or risk factors.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.